STAT+: Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may await
The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.
2 days ago STAT News
Search
148 stories found
STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years
UniQure's gene therapy continues to slow Huntington's progression after four years. But the magnitude of the benefit waned compared to a similar analysis from a year ago.
2 days ago STAT News
Opinion: Claude analyzed my genome in 30 minutes. Now we need standards for the results
In 2009, analyzing Euan Ashley’s whole genome took 30 people and almost a year. In 2026, he writes, Claude did it in 30 minutes for about $5.
2 days ago STAT News
STAT+: Two key Senate health committees face major shake-ups
Senate committees that handle important health care matters are about to see major GOP turnover. Here's what that means.
2 days ago STAT News
STAT+: Can a top Republican from a bygone political era fix pharma’s woes in Washington?
In Washington, Eric Cantor will confront bipartisan backlash over rising health care costs.
2 days ago STAT News
STAT+: In Shanghai’s ‘Science City,’ China’s ascendant biotechs make their pitch to the world
A small conference with big ambitions mirrors the rapid growth of Chinese biotech, invites comparisons to U.S. biotech gathering also known for deal-making.
2 days ago STAT News
Does GLP-1 use result in significant hair loss?
Covered by The Guardian – Health, STAT News. Experts share what you need to know about GLP-1-related hair loss as the side-effect gets more attention from researchers About 20 million people across the US, UK, and EU are taking GLP-1 receptor agonists like…
2 days ago 2 sources
STAT+: Sanofi, Regeneron expand partnership after Dupixent success
Sanofi and Regeneron have re-upped their collaboration pact, aiming to build on the blockbuster success of the drug Dupixent.
2 days ago STAT News
STAT+: UnitedHealth investor lawsuit moves forward on allegations it ‘manufactured earnings’ to hide declining profits
An investor lawsuit against UnitedHealth Group will move forward after a federal judge declined the company’s motion to dismiss allegations.
3 days ago STAT News
STAT+: HHS announces new efforts to speed up, expand clinical trials with AI
Federal health officials want to speed up clinical research to compete with countries like China.
3 days ago STAT News
U.S. poised to boot legal immigrants from Medicaid, including refugees and sex-trafficking victims
Hundreds of thousands of immigrants with legal status, including refugees and sex-trafficking victims, are at risk of losing government health coverage starting Oct. 1.
3 days ago STAT News
STAT+: What health tech leaders are talking about in Washington policy circles
In this edition of AI Prognosis: Dispatches from Health Datapalooza and MAHA Institute Open Data Summit, and other health AI news.
3 days ago STAT News
STAT+: Eli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial
An investigational combination therapy from Eli Lilly led to significant weight loss in a mid-stage study, but high discontinuation rates raise questions about tolerability.
3 days ago STAT News
Rural MAHA followers say Trump hasn’t improved health of their communities, poll finds
About half of rural voters identify with MAHA movement, but most said President Trump’s health care policies have not benefited their communities, according to a new poll.
3 days ago STAT News
STAT+: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property
The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to co-found a Chinese company that made a deal with VC firms.
3 days ago STAT News
Opinion: STAT+: What to think about those mice with half-human brains
New research involving giving mice a human cell-based cortex brings to mind “Flowers for Algernon” and “Pinky and the Brain,” writes STAT Lab Dish columnist Paul Knoepfler.
3 days ago STAT News
Kratom and 7-OH should be regulated, experts agree. They’re split on how
Kratom has skirted regulation for decades, but newer, highly concentrated 7-OH products have renewed interest in safeguards.
3 days ago STAT News
Opinion: America’s biotech race with China must be won at home
“The surest way to secure our biotech lead is to build up our own capabilities,” write Gary Locke and Patrick McHenry.
3 days ago STAT News
STAT+: Lawmakers urge Trump to rethink new rule that could restrict imported meds from Canada and overseas
Some lawmakers are urging the Trump administration to rethink a pending rule that may prevent Americans from obtaining medicines from licensed international pharmacies.
4 days ago STAT News
STAT+: PhRMA taps Eric Cantor as new CEO
Eric Cantor, a former GOP House majority leader, is taking the helm of PhRMA at a challenging time for the industry.
4 days ago STAT News